Results 301 to 310 of about 622,897 (403)

Individualizing dialysis dose under certain circumstances during the Severe Acute Respiratory Syndrome Coronavirus-2 (coronavirus disease 2019) pandemic: a perspective [PDF]

, 2020
Tarek Samy Abdelaziz
openalex   +1 more source

Change in healthcare utilization before and after COVID‐19 using data from 1.5 million individuals

Journal of Internal Medicine, EarlyView.
Abstract Background and objective Post‐infectious sequelae can increase burden on healthcare systems. We aimed to assess the long‐term effect of COVID‐19 on healthcare utilization across all levels of care. Methods In this register‐based cohort study, we included all adult (≥18 years) residents in Sweden's two largest counties with a registered COVID ...
Maria Bygdell, Erik Bülow, Simon B. Larsson, Robert Sigström, Huiqi Li, Jari Martikainen, Ailiana Santosa, Lisa Lundberg‐Morris, Susannah Leach, Magnus Gisslén, Carl Bonander, Jörgen Månsson, Kristoffer Strålin, Fredrik Nyberg   +13 more
wiley   +1 more source

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. [PDF]

J Infect Dis
Atmar RL, Lyke KE, Posavad CM, Deming ME, Brady RC, Dobrzynski D, Edupuganti S, Mulligan MJ, Rupp RE, Rostad CA, Jackson LA, Martin JM, Shriver MC, Rajakumar K, Coler RN, El Sahly HM, Kottkamp AC, Branche AR, Frenck RW, Johnston C, Babu TM, Bäcker M, Archer JI, Crandon S, Nakamura A, Nayak SU, Szydlo D, Dominguez Islas CP, Brown ER, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Beigel JH, Pasetti M, Roberts PC.   +36 more
europepmc   +1 more source

Factors Associated With Craniocervical and Otological Symptoms in Healthcare Workers During Covid‐19 Pandemic: A Cross‐Sectional Study

Journal of Oral Rehabilitation, EarlyView.
Healthcare workers experienced increased craniocervical and otological symptoms during the COVID‐19 pandemic. ABSTRACT Background Increased personal protective equipment (PPE) use, working hours and psychological disorders were observed among healthcare workers during the COVID‐19 pandemic, possibly leading to craniocervical and otological symptoms ...
Anita Almeida Gonzaga, Jade Louise Alves Macedo Padilha Silva, Rafaella Silva dos Santos Aguiar Gonçalves, Luiz Felipe Tavares, Álvaro Campos Cavalcanti Maciel, Karyna Myrelly Oliveira Bezerra Figueiredo Ribeiro   +5 more
wiley   +1 more source

Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2. [PDF]

J Virol
Farrukee R, Mordant F, Mackenzie-Kludas C, Mesner D, Yamomoto M, Jolly C, Brooks AG, Subbarao K, Londrigan SL, Reading PC.   +9 more
europepmc   +1 more source

Association between obstructive sleep apnea (OSA) and COVID‐19 severity

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Obstructive sleep apnea and sleep‐related hypoxia have been associated with higher rates of hospitalization and mortality among patients with Coronavirus disease 2019 (COVID‐19). We further explored the association between obstructive sleep apnea, COVID‐19 severity and related mortality.
Oria Nassi‐Liberman, Bernice Oberman, Tamar Strahl, Noga Yosef, Dekel Shlomi   +4 more
wiley   +1 more source

The Effect of Preexisting Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Infection Outcomes in Exposed Household Members. [PDF]

J Infect Dis
Westerhof I, Sikkema R, Rozhnova G, van Beek J, Koopmans M, Bruijning-Verhagen P.   +5 more
europepmc   +1 more source

Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome

Neurogastroenterology &Motility, EarlyView.
ABSTRACT Background Exposure to COVID‐19 has been shown previously to be associated with a higher risk for irritable bowel syndrome (IBS). This study aimed to better explain this relationship using mediation analysis. Methods This post hoc analysis of a multicenter cohort study includes 623 patients with and without COVID‐19 infection. All participants
Keren Hod, Giovanni Marasco, Luigi Colecchia, Cesare Cremon, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Egidia Miftode, Pietro Fusaroli, Salem Youssef Mohamed, Chiara Ricci, Massimo Bellini, M. Masudur Rahman, Luigi Melcarne, Javier Santos, Beatriz Lobo, Serhat Bor, Suna Yapali, Deniz Akyol, Ferdane Pirincci Sapmaz, Yonca Yilmaz Urun, Tugce Eskazan, Altay Celebi, Huseyin Kacmaz, Berat Ebik, Hatice Cilem Binicier, Mehmet Sait Bugdayci, Munkhtsetseg Banzragch Yağcı, Husnu Pullukcu, Berrin Yalınbas Kaya, Ali Tureyen, İbrahim Hatemi, Elif Sitre Koc, Goktug Sirin, Ali Riza Calıskan, Goksel Bengi, Esra Ergun Alıs, Snezana Lukic, Meri Trajkovska, Dan Dumitrascu, Antonello Pietrangelo, Elena Corradini, Magnus Simren, Jessica Sjolund, Navkiran Tornkvist, Uday C. Ghoshal, Olga Kolokolnikova, Antonio Colecchia, Jordi Serra, Giovanni Maconi, Roberto De Giorgio, Silvio Danese, Piero Portincasa, Antonio Di Sabatino, Marcello Maggio, Elena Philippou, Yeong Yeh Lee, Daniele Salvi, Alessandro Venturi, Claudio Borghi, Marco Zoli, Paolo Gionchetti, Pierluigi Viale, Vincenzo Stanghellini, Giovanni Barbara, on behalf of GI‐COVID19 study group   +68 more
wiley   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines

Pediatric Infectious Disease Journal, 2020
openaire   +4 more sources

Incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in North Carolina from December 2020 - February 2022. [PDF]

PLoS One
Miller EM, Boyce RM, Kipp AM, Newby LK, Woods CW, Cassidy CA, Gunderson AK, Lea CS, Neighbors CE, Shook-Sa BE, Sloane R, Starling AP, Wambui D, Wixted D, Fleischauer A, Aiello AE.   +15 more
europepmc   +1 more source